| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,713 | 7,708 | 8,115 | 6,648 | | Cost of Revenue | 2,154 | 2,355 | 2,553 | 2,896 | | | Gross Profit |
-
| 5,353 | 5,562 | 3,752 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,054 | 3,825 | 4,263 | 4,521 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 793 | 1,484 | 3,472 | 6,589 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 44 | (2,172) | (7,358) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (288) | 44 | (2,172) | (7,358) | | Interest Expense | 433 | 440 | 464 | 467 | | Income Before Tax | (722) | (396) | (2,636) | (7,825) | | Income Tax Expense | (297) | (152) | (702) | (2,925) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (425) | (245) | (1,935) | (4,900) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (425) | (245) | (1,935) | (4,900) | | Preferred Stock And Other Adjustments | (140) | (140) | (140) | (47) | | | Net Income Applicable To Common Shares | ($565) | ($384) | ($2,074) | ($4,946) |
|
0.09% Nasdaq 
0.37%
Income Statement
